We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
We spoke to Prof. Dr. med. Wolfram-Hubertus Zimmermann, Director of the Institute of Pharmacology and Toxicology, University Medical Centre Goettingen, Germany. He described his interest in tissue engineering, and his research group's aim to develop mature muscle tissue for drug screening and organ repair.
He highlights the applications and limitations of engineered tissue and the relationship between quantity and quality.
